Analystreport

Acer Therapeutics (NASDAQ: ACER) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating.

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations